<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Nonalcoholic <z:hpo ids='HP_0001397'>fatty liver</z:hpo> disease (NAFLD) is now the most frequent <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0023895" disease_type="Disease or Syndrome" abbrv="">liver disease</z:e> in Western societies, affecting one in four adults in the USA, and is strongly associated with hepatic <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, a major risk factor in the pathogenesis of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Although the cellular mechanisms underlying this relationship are unknown, hepatic accumulation of diacylglycerol (DAG) in both animals and humans has been linked to hepatic <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>In this Perspective, we discuss the role of DAG activation of protein kinase CÎµ as the mechanism responsible for NAFLD-associated hepatic <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> seen in <z:hpo ids='HP_0001513'>obesity</z:hpo>, type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, and <z:hpo ids='HP_0009125'>lipodystrophy</z:hpo> </plain></SENT>
</text></document>